Диарилпиримидины (:ngjnlhnjnbn;nud)

Диарилпиримидины (DAPY) и диарилтриазины (DATA) представляют собой два тесно связанных класса молекул, напоминающих пиримидиновые нуклеотиды, обнаруженные в ДНК. Они показывают большую эффективность в подавлении активности обратной транскриптазы ВИЧ^[1]^[2]. Некоторые соединения этого класса представляют собой ненуклеозидные ингибиторы обратной транскриптазы, используемые в клинической практике при лечении ВИЧ/СПИДа^[3]^[4], особенно этравирин^[5] и рилпивирин^[6].

Примечания

↑ Van Herrewege Y, Vanham G, Michiels J, Fransen K, Kestens L, Andries K, Janssen P, Lewi P (2004). "A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides". Antimicrob. Agents Chemother. 48 (10): 3684—9. doi:10.1128/AAC.48.10.3684-3689.2004. PMC 521893. PMID 15388420.
↑ Mordant C, Schmitt B, Pasquier E, Demestre C, Queguiner L, Masungi C, Peeters A, Smeulders L, Bettens E, Hertogs K, Heeres J, Lewi P, Guillemont J (2007). "Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains". Eur J Med Chem. 42 (5): 567—79. doi:10.1016/j.ejmech.2006.11.014. PMID 17223230.
↑ Goebel F, Yakovlev A, Pozniak AL, Vinogradova E, Boogaerts G, Hoetelmans R, de Béthune MP, Peeters M, Woodfall B (2006). "Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects". AIDS. 20 (13): 1721—6. doi:10.1097/01.aids.0000242818.65215.bd. PMID 16931936.
↑ Fang C, Bauman JD, Das K, Remorino A, Arnold E, Hochstrasser RM (2007). "Two-dimensional infrared spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase". Proc Natl Acad Sci USA. 105 (5): 1472—7. doi:10.1073/pnas.0709320104. PMC 2234168. PMID 18040050.
↑ Das K, Clark AD, Lewi PJ, Heeres J, De Jonge MR, Koymans LM, Vinkers HM, Daeyaert F, Ludovici DW, Kukla MJ, De Corte B, Kavash RW, Ho CY, Ye H, Lichtenstein MA, Andries K, Pauwels R, De Béthune MP, Boyer PL, Clark P, Hughes SH, Janssen PA, Arnold E (2004). "Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants". J. Med. Chem. 47 (10): 2550—60. doi:10.1021/jm030558s. PMID 15115397.
↑ Steve Mitchell. HIV Market To Top 10 Billion Dollars Архивная копия от 14 августа 2019 на Wayback Machine. United Press International. April 11, 2007.

[1] Van Herrewege Y, Vanham G, Michiels J, Fransen K, Kestens L, Andries K, Janssen P, Lewi P (2004). "A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides". Antimicrob. Agents Chemother. 48 (10): 3684—9. doi:10.1128/AAC.48.10.3684-3689.2004. PMC 521893. PMID 15388420.

[2] Mordant C, Schmitt B, Pasquier E, Demestre C, Queguiner L, Masungi C, Peeters A, Smeulders L, Bettens E, Hertogs K, Heeres J, Lewi P, Guillemont J (2007). "Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains". Eur J Med Chem. 42 (5): 567—79. doi:10.1016/j.ejmech.2006.11.014. PMID 17223230.

[3] Goebel F, Yakovlev A, Pozniak AL, Vinogradova E, Boogaerts G, Hoetelmans R, de Béthune MP, Peeters M, Woodfall B (2006). "Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects". AIDS. 20 (13): 1721—6. doi:10.1097/01.aids.0000242818.65215.bd. PMID 16931936.

[4] Fang C, Bauman JD, Das K, Remorino A, Arnold E, Hochstrasser RM (2007). "Two-dimensional infrared spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase". Proc Natl Acad Sci USA. 105 (5): 1472—7. doi:10.1073/pnas.0709320104. PMC 2234168. PMID 18040050.

[pmid15115397-5] Das K, Clark AD, Lewi PJ, Heeres J, De Jonge MR, Koymans LM, Vinkers HM, Daeyaert F, Ludovici DW, Kukla MJ, De Corte B, Kavash RW, Ho CY, Ye H, Lichtenstein MA, Andries K, Pauwels R, De Béthune MP, Boyer PL, Clark P, Hughes SH, Janssen PA, Arnold E (2004). "Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants". J. Med. Chem. 47 (10): 2550—60. doi:10.1021/jm030558s. PMID 15115397.

[6] Steve Mitchell. HIV Market To Top 10 Billion Dollars Архивная копия от 14 августа 2019 на Wayback Machine. United Press International. April 11, 2007.

[1]

[2]

[3]

[4]

[5]

[6]